Clinical Trial: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: A Double-blind, Double Dummy, Randomized Crossover Trial to Compare the Effect of "AIC316 (Pritelivir)" 100 mg Once Daily Versus Valacyclovir 500 mg Once Daily on Genit

Brief Summary: The aim of the study is to evaluate the safety and efficacy of "AIC316 (pritelivir)" 100 mg once daily compared to valacyclovir 500 mg once daily for the prevention of HSV-2 genital shedding.